The global market for OAB Treatment was valued at US$ 5079 million in the year 2024 and is projected to reach a revised size of US$ 5617 million by 2031, growing at a CAGR of 1.5% during the forecast period.

OAB Treatment Market

Overactive bladder (OAB) is a common disease characterized by urinary urgency, often accompanied by frequent urination and nocturia, with or without urge urinary incontinence. This report focuses on the OAB treatment drug market, which is divided into: anticholinergic drugs, Mirabegron, Botox and others by drug type.

Overactive bladder (OAB) is a common disease, and the incidence of OAB shows an upward trend with age. With the continuous increase in the global elderly population, the number of elderly OAB patients has shown an upward trend year by year, which has attracted further attention from governments and the pharmaceutical treatment market. The OAB treatment drug market has great potential. The introduction of pharmaceutical industry policies, the policy changes and market environment, and the policy trends and future market development trends, although there are challenges, are actually evolving in a direction that is beneficial to innovative enterprises, which is conducive to promoting the long-term standardized development of the industry and providing good opportunities for OAB new drug companies with high-level R&D, production and quality management systems. It will be conducive to promoting the development of the OAB treatment drug industry. With the continuous advancement of technology and the innovation of new instruments, the surge in the number of new drugs discovered, the increase in government funds and the undeveloped emerging markets will further generate profitable markets, thereby promoting the market growth of OAB drugs. With the continuous increase in global healthcare infrastructure spending, the increase in per capita disposable income and the expansion of medical insurance coverage, residents' ability to pay for medical care has increased, driving the development of the OAB drug industry.

This report aims to provide a comprehensive presentation of the global market for OAB Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OAB Treatment.

The OAB Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OAB Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the OAB Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of OAB Treatment Market Report

Report Metric	Details
Report Name	OAB Treatment Market
Accounted market size in year	US$ 5079 million
Forecasted market size in 2031	US$ 5617 million
CAGR	1.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Anticholinergics Mirabegron Botox Others
Segment by Application	Idiopathic Overactive Bladder Neurogenic Overactive Bladder
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Astellas Pharma, Pfizer, Teva, Johnson & Johnson, Kyorin Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OAB Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is OAB Treatment Market growing?

Ans: The OAB Treatment Market witnessing a CAGR of 1.5% during the forecast period 2025-2031.

What is the OAB Treatment Market size in 2031?

Ans: The OAB Treatment Market size in 2031 will be US$ 5617 million.

Who are the main players in the OAB Treatment Market report?

Ans: The main players in the OAB Treatment Market are AbbVie, Astellas Pharma, Pfizer, Teva, Johnson & Johnson, Kyorin Pharmaceutical

What are the Application segmentation covered in the OAB Treatment Market report?

Ans: The Applications covered in the OAB Treatment Market report are Idiopathic Overactive Bladder, Neurogenic Overactive Bladder

What are the Type segmentation covered in the OAB Treatment Market report?

Ans: The Types covered in the OAB Treatment Market report are Anticholinergics, Mirabegron, Botox, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global OAB Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Anticholinergics

1.2.3 Mirabegron

1.2.4 Botox

1.2.5 Others

1.3 Market by Application

1.3.1 Global OAB Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Idiopathic Overactive Bladder

1.3.3 Neurogenic Overactive Bladder

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global OAB Treatment Market Perspective (2020-2031)

2.2 Global OAB Treatment Growth Trends by Region

2.2.1 Global OAB Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 OAB Treatment Historic Market Size by Region (2020-2025)

2.2.3 OAB Treatment Forecasted Market Size by Region (2026-2031)

2.3 OAB Treatment Market Dynamics

2.3.1 OAB Treatment Industry Trends

2.3.2 OAB Treatment Market Drivers

2.3.3 OAB Treatment Market Challenges

2.3.4 OAB Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top OAB Treatment Players by Revenue

3.1.1 Global Top OAB Treatment Players by Revenue (2020-2025)

3.1.2 Global OAB Treatment Revenue Market Share by Players (2020-2025)

3.2 Global OAB Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by OAB Treatment Revenue

3.4 Global OAB Treatment Market Concentration Ratio

3.4.1 Global OAB Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by OAB Treatment Revenue in 2024

3.5 Global Key Players of OAB Treatment Head office and Area Served

3.6 Global Key Players of OAB Treatment, Product and Application

3.7 Global Key Players of OAB Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 OAB Treatment Breakdown Data by Type

4.1 Global OAB Treatment Historic Market Size by Type (2020-2025)

4.2 Global OAB Treatment Forecasted Market Size by Type (2026-2031)

5 OAB Treatment Breakdown Data by Application

5.1 Global OAB Treatment Historic Market Size by Application (2020-2025)

5.2 Global OAB Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America OAB Treatment Market Size (2020-2031)

6.2 North America OAB Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America OAB Treatment Market Size by Country (2020-2025)

6.4 North America OAB Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe OAB Treatment Market Size (2020-2031)

7.2 Europe OAB Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe OAB Treatment Market Size by Country (2020-2025)

7.4 Europe OAB Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific OAB Treatment Market Size (2020-2031)

8.2 Asia-Pacific OAB Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific OAB Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific OAB Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America OAB Treatment Market Size (2020-2031)

9.2 Latin America OAB Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America OAB Treatment Market Size by Country (2020-2025)

9.4 Latin America OAB Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa OAB Treatment Market Size (2020-2031)

10.2 Middle East & Africa OAB Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa OAB Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa OAB Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie OAB Treatment Introduction

11.1.4 AbbVie Revenue in OAB Treatment Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Astellas Pharma

11.2.1 Astellas Pharma Company Details

11.2.2 Astellas Pharma Business Overview

11.2.3 Astellas Pharma OAB Treatment Introduction

11.2.4 Astellas Pharma Revenue in OAB Treatment Business (2020-2025)

11.2.5 Astellas Pharma Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer OAB Treatment Introduction

11.3.4 Pfizer Revenue in OAB Treatment Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Teva

11.4.1 Teva Company Details

11.4.2 Teva Business Overview

11.4.3 Teva OAB Treatment Introduction

11.4.4 Teva Revenue in OAB Treatment Business (2020-2025)

11.4.5 Teva Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson OAB Treatment Introduction

11.5.4 Johnson & Johnson Revenue in OAB Treatment Business (2020-2025)

11.5.5 Johnson & Johnson Recent Development

11.6 Kyorin Pharmaceutical

11.6.1 Kyorin Pharmaceutical Company Details

11.6.2 Kyorin Pharmaceutical Business Overview

11.6.3 Kyorin Pharmaceutical OAB Treatment Introduction

11.6.4 Kyorin Pharmaceutical Revenue in OAB Treatment Business (2020-2025)

11.6.5 Kyorin Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Kyorin Pharmaceutical

List of Tables

Table 1. Global OAB Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Anticholinergics

Table 3. Key Players of Mirabegron

Table 4. Key Players of Botox

Table 5. Key Players of Others

Table 6. Global OAB Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global OAB Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global OAB Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global OAB Treatment Market Share by Region (2020-2025)

Table 10. Global OAB Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global OAB Treatment Market Share by Region (2026-2031)

Table 12. OAB Treatment Market Trends

Table 13. OAB Treatment Market Drivers

Table 14. OAB Treatment Market Challenges

Table 15. OAB Treatment Market Restraints

Table 16. Global OAB Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global OAB Treatment Market Share by Players (2020-2025)

Table 18. Global Top OAB Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OAB Treatment as of 2024)

Table 19. Ranking of Global Top OAB Treatment Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by OAB Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of OAB Treatment, Headquarters and Area Served

Table 22. Global Key Players of OAB Treatment, Product and Application

Table 23. Global Key Players of OAB Treatment, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global OAB Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global OAB Treatment Revenue Market Share by Type (2020-2025)

Table 27. Global OAB Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global OAB Treatment Revenue Market Share by Type (2026-2031)

Table 29. Global OAB Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global OAB Treatment Revenue Market Share by Application (2020-2025)

Table 31. Global OAB Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global OAB Treatment Revenue Market Share by Application (2026-2031)

Table 33. North America OAB Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America OAB Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America OAB Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe OAB Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe OAB Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe OAB Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific OAB Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific OAB Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific OAB Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America OAB Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America OAB Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America OAB Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa OAB Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa OAB Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa OAB Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. AbbVie Company Details

Table 49. AbbVie Business Overview

Table 50. AbbVie OAB Treatment Product

Table 51. AbbVie Revenue in OAB Treatment Business (2020-2025) & (US$ Million)

Table 52. AbbVie Recent Development

Table 53. Astellas Pharma Company Details

Table 54. Astellas Pharma Business Overview

Table 55. Astellas Pharma OAB Treatment Product

Table 56. Astellas Pharma Revenue in OAB Treatment Business (2020-2025) & (US$ Million)

Table 57. Astellas Pharma Recent Development

Table 58. Pfizer Company Details

Table 59. Pfizer Business Overview

Table 60. Pfizer OAB Treatment Product

Table 61. Pfizer Revenue in OAB Treatment Business (2020-2025) & (US$ Million)

Table 62. Pfizer Recent Development

Table 63. Teva Company Details

Table 64. Teva Business Overview

Table 65. Teva OAB Treatment Product

Table 66. Teva Revenue in OAB Treatment Business (2020-2025) & (US$ Million)

Table 67. Teva Recent Development

Table 68. Johnson & Johnson Company Details

Table 69. Johnson & Johnson Business Overview

Table 70. Johnson & Johnson OAB Treatment Product

Table 71. Johnson & Johnson Revenue in OAB Treatment Business (2020-2025) & (US$ Million)

Table 72. Johnson & Johnson Recent Development

Table 73. Kyorin Pharmaceutical Company Details

Table 74. Kyorin Pharmaceutical Business Overview

Table 75. Kyorin Pharmaceutical OAB Treatment Product

Table 76. Kyorin Pharmaceutical Revenue in OAB Treatment Business (2020-2025) & (US$ Million)

Table 77. Kyorin Pharmaceutical Recent Development

Table 78. Research Programs/Design for This Report

Table 79. Key Data Information from Secondary Sources

Table 80. Key Data Information from Primary Sources

Table 81. Authors List of This Report

List of Figures

Figure 1. OAB Treatment Picture

Figure 2. Global OAB Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global OAB Treatment Market Share by Type: 2024 VS 2031

Figure 4. Anticholinergics Features

Figure 5. Mirabegron Features

Figure 6. Botox Features

Figure 7. Others Features

Figure 8. Global OAB Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global OAB Treatment Market Share by Application: 2024 VS 2031

Figure 10. Idiopathic Overactive Bladder Case Studies

Figure 11. Neurogenic Overactive Bladder Case Studies

Figure 12. OAB Treatment Report Years Considered

Figure 13. Global OAB Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global OAB Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global OAB Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global OAB Treatment Market Share by Players in 2024

Figure 17. Global Top OAB Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OAB Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by OAB Treatment Revenue in 2024

Figure 19. North America OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America OAB Treatment Market Share by Country (2020-2031)

Figure 21. United States OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe OAB Treatment Market Share by Country (2020-2031)

Figure 25. Germany OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific OAB Treatment Market Share by Region (2020-2031)

Figure 33. China OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America OAB Treatment Market Share by Country (2020-2031)

Figure 41. Mexico OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa OAB Treatment Market Share by Country (2020-2031)

Figure 45. Turkey OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE OAB Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. AbbVie Revenue Growth Rate in OAB Treatment Business (2020-2025)

Figure 49. Astellas Pharma Revenue Growth Rate in OAB Treatment Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in OAB Treatment Business (2020-2025)

Figure 51. Teva Revenue Growth Rate in OAB Treatment Business (2020-2025)

Figure 52. Johnson & Johnson Revenue Growth Rate in OAB Treatment Business (2020-2025)

Figure 53. Kyorin Pharmaceutical Revenue Growth Rate in OAB Treatment Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions